Blaise Coleman

Mr. Blaise A. Coleman is an Independent Director at Ocugen, Inc., a Chairman at Generics International (US), Inc., a Chairman at Innoteq, Inc., a Chairman at Par Pharmaceutical Cos., Inc. (New York), a Chairman at Par Pharmaceutical Holdings, Inc. and a Chairman at Par Pharmaceutical, Inc. He is on the Board of Directors at Ocugen, Inc., Auxilium Pharmaceuticals LLC, Endo Innovation Valera LLC, Par Sterile Products LLC, Slate Pharmaceuticals LLC and Vintage Pharmaceuticals LLC.
Mr. Coleman was previously employed as a Chairman, President & Chief Executive Officer by BioSpecifics Technologies Corp., a President, Chief Executive Officer & Director by Endo International Plc, a Chief Financial Officer by AstraZeneca AB, a Senior Director-Commercial Finance by AstraZeneca US Investments Ltd., and a President, Chief Executive Officer & Director by Endo, Inc. He received his undergraduate degree from Widener University and an MBA from The Fuqua School of Business.